| Previous Close | 43.13 |
| Open | 43.10 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 42.60 - 43.44 |
| 52 Week Range | 18.25 - 45.55 |
| Volume | 425,327 |
| Avg. Volume | 434,751 |
| Market Cap | 1.44B |
| Beta | 1.51 |
| PE Ratio (TTM) | -21,550.00 |
| EPS (TTM) | -0 |
| Earnings Date | Oct 24, 2017 - Oct 30, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.83 |
- Zacks•3 days ago
Quidel Corporation (QDEL) Jumps: Stock Rises 6.5%
Quidel Corporation (QDEL) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.
Motley Fool•4 days agoHere's Why Quidel Corporation Stock Is Popping Today
Investors appear pleased with a recent revision to a deal with another point-of-care diagnostic developer.
- Business Wire•6 days ago
Quidel Announces Revised Agreement for Its Pending Acquisition of Alere’s B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced a revised definitive agreement with Alere Inc.
